Mediwound Ltd (MDWD)vsRevolution Medicines Inc (RVMD)
MDWD
Mediwound Ltd
$14.18
-1.87%
HEALTHCARE · Cap: $182.76M
RVMD
Revolution Medicines Inc
$155.69
+3.31%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Mediwound Ltd generates 1851% more annual revenue ($14.48M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -180.3%. RVMD earns a higher WallStSmart Score of 24/100 (F).
MDWD
Avoid18
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+55.0%
Fair Value
$38.36
Current Price
$14.18
$24.18 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -63.0% — below average capital efficiency
Revenue declined 62.7%
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MDWD
The strongest argument for MDWD centers on Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : MDWD
The primary concerns for MDWD are EPS Growth, Market Cap, Return on Equity.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
MDWD profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
MDWD is growing revenue faster at -62.7% — sustainability is the question.
MDWD generates stronger free cash flow (-9M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 18/100). MDWD offers better value entry with a 55.0% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Mediwound Ltd
HEALTHCARE · BIOTECHNOLOGY · USA
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?